Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 1
1956 1
1960 1
1961 1
1962 2
1963 3
1964 3
1965 5
1967 1
1968 1
1969 2
1970 5
1971 2
1973 2
1974 2
1975 1
1976 2
1977 5
1978 2
1979 2
1980 7
1981 3
1982 1
1983 1
1984 2
1985 3
1986 2
1987 3
1988 3
1989 3
1990 3
1991 3
1993 4
1994 6
1995 1
1996 1
1997 3
1998 7
1999 4
2000 4
2001 3
2003 1
2004 1
2005 3
2006 8
2007 4
2008 3
2009 2
2010 5
2011 15
2012 32
2013 10
2014 9
2015 5
2016 5
2017 12
2018 8
2019 10
2020 10
2021 6
2022 7
2023 8
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).
Prasad SM, Huang WC, Shore ND, Hu B, Bjurlin M, Brown G, Genov P, Shishkov D, Khuskivadze A, Ganev T, Marchev D, Orlov I, Kopyltsov E, Zubarev V, Nosov A, Komlev D, Burger B, Raju S, Meads A, Schoenberg M. Prasad SM, et al. Among authors: orlov i. J Urol. 2023 Oct;210(4):619-629. doi: 10.1097/JU.0000000000003645. Epub 2023 Aug 7. J Urol. 2023. PMID: 37548555 Clinical Trial.
[Micropercutaneous laser nephrolithotripsy].
Martov AG, Dutov SV, Popov SV, Emelyanenko AV, Andronov AS, Orlov IN, Adilhanov MM, Kozachihina SI. Martov AG, et al. Among authors: orlov in. Urologiia. 2019 Jul;(3):72-79. Urologiia. 2019. PMID: 31356016 Russian.
Urethral leiomyoma: A rare neoplasm.
Popov SV, Orlov IN, Chernysheva DY, Grin' EA. Popov SV, et al. Among authors: orlov in. Urol Ann. 2021 Apr-Jun;13(2):194-197. doi: 10.4103/UA.UA_90_20. Epub 2021 Mar 4. Urol Ann. 2021. PMID: 34194152 Free PMC article.
Morphological Diversity of Dps Complex with Genomic DNA.
Chesnokov Y, Kamyshinsky R, Mozhaev A, Shtykova E, Vasiliev A, Orlov I, Dadinova L. Chesnokov Y, et al. Among authors: orlov i. Int J Mol Sci. 2023 May 10;24(10):8534. doi: 10.3390/ijms24108534. Int J Mol Sci. 2023. PMID: 37239879 Free PMC article.
277 results